Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

--
Delayed Data
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
--

Company Description

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of pharmaceutical product candidates that focuses on the treatment of obesity. Its sole product, Contrave, functions as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management. The company was founded Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

Contact Information

Orexigen Therapeutics, Inc.
3344 North Torrey Pines Court
La Jolla California 92037
P:(858) 875-8600
Investor Relations:

Employees

Shareholders

Other institutional37.26%
Individual stakeholders31.99%
Mutual fund holders20.76%

Top Executives

Michael A. NarachiPresident, Chief Executive Officer & Director
Thomas R. CannellChief Operating Officer & Executive Vice President
Jason KeyesChief Financial Officer & Senior Vice President
Thomas P. LynchSecretary, Executive VP & General Counsel
Beth EastlandVice President-Sales